Viimeaikaiset hankinnat, joissa toimittaja on mainittu GlaxoSmithKline Oy
2023-03-30Hepatitis A Vaccine (HAV) for children/adolescents and adults 2023 - 2025 (2025 - 2027) (Ministry of Social Affairs and Health)
The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Hepatitis A Vaccine (HAV) belonging to the National Vaccination Programme in Finland.
The contract period is about two years 2023−2025. The procurement contains two options (1+1) to extend the contract for the periods 2025−2026 and 2026−2027.
Estimated quantity for the contract period including option is 2700 doses (2000 doses for adults and …
Näytä hankinnat » Mainitut toimittajat:GlaxoSmithKline Oy
2023-03-30Meningococcal Group B Vaccine 2024-2025 (2026, 2027) (Ministry of Social Affairs and Health)
The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Meningococcal Group B Vaccine belonging to the National Vaccination Programme in Finland.
The contract period is about two years during 2024-2025. The procurement contains two options to extend the contract for the years 2026 and 2027.
Estimated quantity for the contract period including option is 4000 doses. Customer reserves the right to …
Näytä hankinnat » Mainitut toimittajat:GlaxoSmithKline Oy
2022-05-19Hepatitis B Vaccine (HBV) for children and adults 2023-2025 (2025-2026, 2026-2027) (Ministry of Social Affairs and Health)
The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Hepatitis B Vaccine belonging to the National Vaccination Programme in Finland.
The contract period is about two years 2023-2025. The procurement contains two options to extend the contract for the periods 2025-2026 and 2026-2027.
Estimated quantity for the contract period including option is 188 000 doses (48 000 doses for children and 140 …
Näytä hankinnat » Mainitut toimittajat:GlaxoSmithKline Oy
2021-11-05Measles, Mumps, Rubella (MMR) Vaccine 2023-2025 (2025-2026, 2026-2027) (Ministry of Social Affairs and Health)
The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Measles, Mumps, Rubella (MMR) Vaccine belonging to the National Vaccination Programme in Finland.
The contract period is about two years during 2023-2025. The procurement contains two options to extend the contract for the periods 2025-2026 and 2026-2027.
Estimated quantity for the contract period including option is 440 000 doses. Customer …
Näytä hankinnat » Mainitut toimittajat:GlaxoSmithKline Oy
2021-11-05Pentavalent (DTaP-IPV+Hib) Vaccine 2023-2024 (2025,2026) (Ministry of Social Affairs and Health)
The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Diphtheria, tetanus, acellular pertussis, polio and Haemophilus influenzae type b (DTaP-IPV-Hib) Vaccine belonging to the National Vaccination Programme in Finland.
The contract period is about two years 2023-2024. The procurement contains two options to extend the contract for the periods 2025 and 2026.
Estimated quantity for the contract …
Näytä hankinnat » Mainitut toimittajat:GlaxoSmithKline Oy
2020-12-22Meningococcal ACWY Conjugate Vaccine (MenACWY) 2021-2023 (2023-2024, 2024-2025) (Ministry of Social Affairs and Health)
The Ministry of Social Affairs and Health (hereinafter ‘STM’) and Finnish institute for health and welfare (hereinafter ‘THL’ or ‘Customer’) request your tender for Meningococcal ACWY (MenACWY) Conjugate Vaccine belonging to the Vaccination Programme in the Finnish Defence Forces and for the medical risk groups within the National Vaccination Programme in Finland.
The contract period is about two years during 2021-2023. The procurement contains two options to extend the contract for the periods 2023-2024 …
Näytä hankinnat » Mainitut toimittajat:GlaxoSmithKline Oy
2019-11-08Human Papillomavirus Vaccine (HPV) 2020-2021 (2022-2023) (Ministry of Social Affairs and Health)
The Ministry of Social Affairs and Health (hereinafter ‘STM’) and finnish institute for health and welfare (hereinafter ‘THL’ or ‘Customer’) request your tender for Human Papillomavirus Vaccine belonging to the National Vaccination Programme in Finland. The contract period is about 2 years 2020-2021. The procurement contains 2 options to extend the contract for the periods 2022 and 2023. Estimated quantity for the contract period including option is 520 000 doses. Customer reserves the right to increase …
Näytä hankinnat » Mainitut toimittajat:GlaxoSmithKline Oy
2018-11-05Human Papillomavirus Vaccine (HPV) 2019-2020 (2020-2021) (National Institute for Health and Welfare)
The Ministry of Social Affairs and Health (hereinafter ”STM”) and National Institute for Health and Welfare (hereinafter "THL" or “Customer”) request your tender for Human Papillomavirus Vaccine (HPV) belonging to the National Vaccination Programme in Finland. The contract period is one year (during 2019-2020). The extend of the contract (option period) is one year (during 2020-2021). Estimated quantity for the contract period including option is 94 000 doses. The customer reserves the right to increase …
Näytä hankinnat » Mainitut toimittajat:GlaxoSmithKline Oy
2018-05-11Hepatitis A Vaccine (HAV) (National Institute for Health and Welfare)
The Ministry of Social Affairs and Health (hereinafter ”STM”) and National Institute for Health and Welfare (hereinafter "THL" or “Customer”) request your tender for Hepatitis A Vaccine (HAV) belonging to the National Vaccination Programme in Finland for risk groups. The number of doses and amounts to be delivered as well as the delivery timetable, are set out in Annex 1 of this Invitation to tender. This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online …
Näytä hankinnat » Mainitut toimittajat:GlaxoSmithKline Oy
2018-05-11Tick-borne Encephalitis (TBE) Vaccine (National Institute for Health and Welfare)
The Ministry of Social Affairs and Health (hereinafter ”STM”) and National Institute for Health and Welfare (hereinafter "THL" or “Customer”) request your tender for Tick-Borne Encephalitis (TBE) Vaccine belonging to the National Vaccination Programme in Finland for risk groups. The number of doses and amounts to be delivered as well as the delivery timetable, are set out in Annex 1 of this Invitation to tender. This procurement is detailed in the contract notice published on TED (Tenders Electronic …
Näytä hankinnat » Mainitut toimittajat:GlaxoSmithKline Oy